Migliaccio & Rathod LLP is currently investigating Bayer HealthCare LLC, the manufacturer of the Seresto flea and tick collar, following reports that this product is linked to 1,700 pet deaths, approximately 11,500 moderate and major injuries involving pets, and over 900 incidents in which humans were harmed. The Seresto collar is the top-selling product of its kind and is available for both dogs and cats. The collar kills and prevents fleas and ticks by releasing pesticides onto the hair and skin of the animal wearing it.
The two active chemicals in the Seresto collar, imidacloprid and flumethrin, are neurotoxins. Acute exposure to these chemicals can cause dizziness, apathy, locomotor effects, labored breathing, and death, along with other undesirable symptoms such as degenerative changes in the testes, thymus, bone marrow and pancreas. Long-term exposure to lower doses is associated with reproductive toxicity, developmental retardation, and neurobehavioral deficits. Ingestion of these chemicals, even at low levels of exposure, is dangerous to pet and human health.
After receiving a public records request from a non-profit environmental watchdog, the U.S. Environmental Protection Agency released documents showing that the agency has received more than 75,000 complaints in the past eight years regarding injuries caused by the collar. This number likely understates the number of actual incidents to pets and humans. Nevertheless, thus far the EPA has done nothing to inform the public of the risks associated with use of the Seresto collar.
Have you or your dog or cat experienced health issues after you purchased and applied a Seresto flea and tick collar to them?
If so, we would like to hear from you. Please fill out the questionnaire below. If you have further questions, please send us an email at firstname.lastname@example.org, or give us a call at (202) 470-3520.
Attorneys Committed to Consumer Protection
The lawyers at Migliaccio & Rathod have years of experience in class action litigation against large corporations, including in cases involving unfair & deceptive trade practices. More information about our current cases and investigations is available on our blog.